HIF1A and nonpapillary renal cell carcinoma: In this study, we performed dual HIF-1α and HIF-2α inhibition using Acriflavine and S1P-signaling inhibition with FTY720 in an autochthonous ccRCC mouse model and human ccRCC cell lines, and showed evidence of a strong anti-cancer effect.